Therapeutic Strategies for Atrial Fibrillation
نویسندگان
چکیده
منابع مشابه
Atrial fibrillation and new therapeutic strategies.
When new therapy challenges a critical disease the clinical spectrum is changed. But although the implantable cardioverter defibrillator is at the forefront of ventricular arrhythmia treatment, the number of implantations per million population remains limited (Fig. 1). The reasons for this poor take up must be one of costs set against the benefits, and indeed, the implantable cardioverter defi...
متن کاملAtrial Fibrillation - Current Understanding and Management Strategies
169 Introduction Atrial Fibrillation (AF) is an arrhythmia characterized by irregular, disorganized and chaotic electrical activity of the atrium. The ECG classically is represented by low amplitude, variable and irregular base-line undulations corresponding to atrial rate in the range of 400-600/min. The ventricular rate is irregularly irregular (Fig. 1). The mean ventricular rate is usually b...
متن کاملDronedarone for atrial fibrillation: a new therapeutic agent
Atrial fibrillation is the most common of the serious cardiac rhythm disturbances and is responsible for substantial morbidity and mortality. Amiodarone is currently one of the most widely used and most effective antiarrhythmic agents for atrial fibrillation. But during chronic usage amiodarone can cause some serious extra cardiac adverse effects, including effects on the thyroid. Dronedarone i...
متن کاملReactive oxygen species-targeted therapeutic interventions for atrial fibrillation
Atrial fibrillation (AF) is the most common arrhythmia that requires medical attention, and its incidence is increasing. Current ion channel blockade therapies and catheter ablation have significant limitations in treatment of AF, mainly because they do not address the underlying pathophysiology of the disease. Oxidative stress has been implicated as a major underlying pathology that promotes A...
متن کاملNovel Therapeutic Options for the Treatment of Nonvalvular Atrial Fibrillation
Objective: To review the literature for the emerging oral anticoagulants, dabigatran, rivaroxaban, and apixaban currently available in the United States. Data Source: A literature review was performed in MEDLINE (1947–July 2014) using the keywords atrial fibrillation AND dabigatran OR rivaroxaban OR apixaban. The references identified from the literature review were then evaluated. All of the l...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Naika Gakkai Zasshi
سال: 2007
ISSN: 0021-5384,1883-2083
DOI: 10.2169/naika.96.1014